158 related articles for article (PubMed ID: 15113392)
21. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of epidermal growth factor receptor restricted to macrophages in uveal melanoma.
Scholes AG; Hagan S; Hiscott P; Damato BE; Grierson I
Arch Ophthalmol; 2001 Mar; 119(3):373-7. PubMed ID: 11231770
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.
All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005
[TBL] [Abstract][Full Text] [Related]
24. Infiltrating macrophages in extratumoural tissues after brachytherapy of uveal melanoma.
Toivonen P; Kivelä T
Acta Ophthalmol; 2012 Jun; 90(4):341-9. PubMed ID: 20809904
[TBL] [Abstract][Full Text] [Related]
25. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium?
Ziemssen F; Wegner R; Wegner J; Tatar O; Süsskind D; Gelisken F; Rohrbach M; Bartz-Schmidt KU; Grisanti S
Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1124-31. PubMed ID: 16523306
[TBL] [Abstract][Full Text] [Related]
26. CD163: a specific marker of macrophages in paraffin-embedded tissue samples.
Lau SK; Chu PG; Weiss LM
Am J Clin Pathol; 2004 Nov; 122(5):794-801. PubMed ID: 15491976
[TBL] [Abstract][Full Text] [Related]
27. Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss.
Coupland SE; Vorum H; Mandal N; Kalirai H; Honoré B; Urbak SF; Lake SL; Dopierala J; Damato B
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):12-20. PubMed ID: 19643972
[TBL] [Abstract][Full Text] [Related]
28. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
[TBL] [Abstract][Full Text] [Related]
29. Digital PCR-Based T-cell Quantification-Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal Melanoma.
de Lange MJ; Nell RJ; Lalai RN; Versluis M; Jordanova ES; Luyten GPM; Jager MJ; van der Burg SH; Zoutman WH; van Hall T; van der Velden PA
Mol Cancer Res; 2018 Dec; 16(12):1902-1911. PubMed ID: 30093564
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of macrophage infiltration in leiomyosarcomas.
Lee CH; Espinosa I; Vrijaldenhoven S; Subramanian S; Montgomery KD; Zhu S; Marinelli RJ; Peterse JL; Poulin N; Nielsen TO; West RB; Gilks CB; van de Rijn M
Clin Cancer Res; 2008 Mar; 14(5):1423-30. PubMed ID: 18316565
[TBL] [Abstract][Full Text] [Related]
31. Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers.
Hendrix MJ; Seftor EA; Seftor RE; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
Lab Invest; 1998 Feb; 78(2):153-63. PubMed ID: 9484713
[TBL] [Abstract][Full Text] [Related]
32. The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma.
Salmi S; Siiskonen H; Sironen R; Tyynelä-Korhonen K; Hirschovits-Gerz B; Valkonen M; Auvinen P; Pasonen-Seppänen S
Melanoma Res; 2019 Jun; 29(3):237-247. PubMed ID: 30399061
[TBL] [Abstract][Full Text] [Related]
33. Inverse correlation between expression of HLA-B and c-myc in uveal melanoma.
Blom DJ; Mooy CM; Luyten GP; Kerkvliet S; Ouwerkerk I; Zwinderman AH; Schrier PI; Jager MJ
J Pathol; 1997 Jan; 181(1):75-9. PubMed ID: 9072006
[TBL] [Abstract][Full Text] [Related]
34. Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma.
Jensen TO; Schmidt H; Møller HJ; Høyer M; Maniecki MB; Sjoegren P; Christensen IJ; Steiniche T
J Clin Oncol; 2009 Jul; 27(20):3330-7. PubMed ID: 19528371
[TBL] [Abstract][Full Text] [Related]
35. Microcirculation and tumor-infiltrating macrophages in choroidal and ciliary body melanoma and corresponding metastases.
Toivonen P; Mäkitie T; Kujala E; Kivelä T
Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):1-6. PubMed ID: 14691146
[TBL] [Abstract][Full Text] [Related]
36. Melanocortin 1 receptor is expressed by uveal malignant melanoma and can be considered a new target for diagnosis and immunotherapy.
López MN; Pereda C; Ramírez M; Mendoza-Naranjo A; Serrano A; Ferreira A; Poblete R; Kalergis AM; Kiessling R; Salazar-Onfray F
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1219-27. PubMed ID: 17325166
[TBL] [Abstract][Full Text] [Related]
37. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
[TBL] [Abstract][Full Text] [Related]
38. Melanoma inhibitory activity: a novel serum marker for uveal melanoma.
Schaller UC; Bosserhoff AK; Neubauer AS; Buettner R; Kampik A; Mueller AJ
Melanoma Res; 2002 Dec; 12(6):593-9. PubMed ID: 12459649
[TBL] [Abstract][Full Text] [Related]
39. CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphoma.
Klein JL; Nguyen TT; Bien-Willner GA; Chen L; Foyil KV; Bartlett NL; Duncavage EJ; Hassan A; Frater JL; Kreisel F
Am J Clin Pathol; 2014 Mar; 141(3):381-7. PubMed ID: 24515766
[TBL] [Abstract][Full Text] [Related]
40. Stimulation and inhibition of uveal melanoma invasion by HGF, GRO, IL-1alpha and TGF-beta.
Woodward JK; Elshaw SR; Murray AK; Nichols CE; Cross N; Laws D; Rennie IG; Sisley K
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3144-52. PubMed ID: 12356817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
